The global market for Therapeutic Companion Tests was valued at US$ 1737 million in the year 2024 and is projected to reach a revised size of US$ 2717 million by 2031, growing at a CAGR of 7.0% during the forecast period.

Therapeutic Companion Tests Market

Therapeutic Companion Tests are diagnostic assays designed to determine the suitability, safety, and effectiveness of a specific therapeutic drug for an individual patient, typically used in precision medicine to guide treatment decisions, optimize dosing, and minimize adverse effects, especially in oncology, immunology, and rare disease management.

Ongoing and planned projects in the therapeutic companion test sector include the development of next-generation sequencing–based companion diagnostics for targeted oncology therapies, partnerships between pharmaceutical companies (e.g., Roche, Novartis, AstraZeneca) and diagnostic firms (e.g., Illumina, Qiagen, Thermo Fisher) to co-develop FDA-approved assays, expansion of companion tests linked to immunotherapy biomarkers such as PD-1/PD-L1 and MSI, regional initiatives to scale molecular diagnostic capacity in Asia-Pacific and the Middle East, and regulatory-driven programs in the U.S. and EU that encourage simultaneous drug–diagnostic co-approvals, ensuring precision medicine adoption continues to accelerate across therapeutic areas.

Market Average Gross Profit Margin: 48%–55%.

North American market for Therapeutic Companion Tests is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Asia-Pacific market for Therapeutic Companion Tests is estimated to increase from $ million in 2024 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The global market for Therapeutic Companion Tests in Oncology is estimated to increase from $ million in 2024 to $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global companies of Therapeutic Companion Tests include Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics, Advanced Cell Diagnostics, Danaher, etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

This report aims to provide a comprehensive presentation of the global market for Therapeutic Companion Tests, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Therapeutic Companion Tests.

The Therapeutic Companion Tests market size, estimations, and forecasts are provided in terms of and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global Therapeutic Companion Tests market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Therapeutic Companion Tests companies, new entrants, and industry chain related companies in this market with information on the revenues for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Therapeutic Companion Tests Market Report

Report Metric	Details
Report Name	Therapeutic Companion Tests Market
Accounted market size in year	US$ 1737 million
Forecasted market size in 2031	US$ 2717 million
CAGR	7.0%
Base Year	year
Forecasted years	2025 - 2031
Segment by Type	Immunohistochemistry Molecular Diagnosis
Segment by Application	Oncology Cardiovascular Central Nervous System Inflammation Virology Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics, Advanced Cell Diagnostics, Danaher, Illumina, Inc
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Therapeutic Companion Tests company competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Therapeutic Companion Tests Market growing?

Ans: The Therapeutic Companion Tests Market witnessing a CAGR of 7.0% during the forecast period 2025-2031.

What is the Therapeutic Companion Tests Market size in 2031?

Ans: The Therapeutic Companion Tests Market size in 2031 will be US$ 2717 million.

Who are the main players in the Therapeutic Companion Tests Market report?

Ans: The main players in the Therapeutic Companion Tests Market are Roche Holdings, Abbott Laboratories, Thermo Fisher Scientific, Agilent Technologies, Merck, Agendia, Qiagen, Myriad Genetics, Advanced Cell Diagnostics, Danaher, Illumina, Inc

What are the Application segmentation covered in the Therapeutic Companion Tests Market report?

Ans: The Applications covered in the Therapeutic Companion Tests Market report are Oncology, Cardiovascular, Central Nervous System, Inflammation, Virology, Others

What are the Type segmentation covered in the Therapeutic Companion Tests Market report?

Ans: The Types covered in the Therapeutic Companion Tests Market report are Immunohistochemistry, Molecular Diagnosis

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Therapeutic Companion Tests Market Size Growth Rate by Type: 2020 VS 2024 VS 2031

1.2.2 Immunohistochemistry

1.2.3 Molecular Diagnosis

1.3 Market by Application

1.3.1 Global Therapeutic Companion Tests Market Growth by Application: 2020 VS 2024 VS 2031

1.3.2 Oncology

1.3.3 Cardiovascular

1.3.4 Central Nervous System

1.3.5 Inflammation

1.3.6 Virology

1.3.7 Others

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Global Growth Trends

2.1 Global Therapeutic Companion Tests Market Perspective (2020-2031)

2.2 Global Therapeutic Companion Tests Growth Trends by Region

2.2.1 Global Therapeutic Companion Tests Market Size by Region: 2020 VS 2024 VS 2031

2.2.2 Therapeutic Companion Tests Historic Market Size by Region (2020-2025)

2.2.3 Therapeutic Companion Tests Forecasted Market Size by Region (2026-2031)

2.3 Therapeutic Companion Tests Market Dynamics

2.3.1 Therapeutic Companion Tests Industry Trends

2.3.2 Therapeutic Companion Tests Market Drivers

2.3.3 Therapeutic Companion Tests Market Challenges

2.3.4 Therapeutic Companion Tests Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Therapeutic Companion Tests Players by Revenue

3.1.1 Global Top Therapeutic Companion Tests Players by Revenue (2020-2025)

3.1.2 Global Therapeutic Companion Tests Revenue Market Share by Players (2020-2025)

3.2 Global Top Therapeutic Companion Tests Players by Company Type and Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Global Key Players Ranking by Therapeutic Companion Tests Revenue

3.4 Global Therapeutic Companion Tests Market Concentration Ratio

3.4.1 Global Therapeutic Companion Tests Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Therapeutic Companion Tests Revenue in 2024

3.5 Global Key Players of Therapeutic Companion Tests Head office and Area Served

3.6 Global Key Players of Therapeutic Companion Tests, Product and Application

3.7 Global Key Players of Therapeutic Companion Tests, Date of Enter into This Industry

3.8 Mergers & Acquisitions, Expansion Plans

4 Therapeutic Companion Tests Breakdown Data by Type

4.1 Global Therapeutic Companion Tests Historic Market Size by Type (2020-2025)

4.2 Global Therapeutic Companion Tests Forecasted Market Size by Type (2026-2031)

5 Therapeutic Companion Tests Breakdown Data by Application

5.1 Global Therapeutic Companion Tests Historic Market Size by Application (2020-2025)

5.2 Global Therapeutic Companion Tests Forecasted Market Size by Application (2026-2031)

6 North America

6.1 North America Therapeutic Companion Tests Market Size (2020-2031)

6.2 North America Therapeutic Companion Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031

6.3 North America Therapeutic Companion Tests Market Size by Country (2020-2025)

6.4 North America Therapeutic Companion Tests Market Size by Country (2026-2031)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Therapeutic Companion Tests Market Size (2020-2031)

7.2 Europe Therapeutic Companion Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031

7.3 Europe Therapeutic Companion Tests Market Size by Country (2020-2025)

7.4 Europe Therapeutic Companion Tests Market Size by Country (2026-2031)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Ireland

8 Asia-Pacific

8.1 Asia-Pacific Therapeutic Companion Tests Market Size (2020-2031)

8.2 Asia-Pacific Therapeutic Companion Tests Market Growth Rate by Region: 2020 VS 2024 VS 2031

8.3 Asia-Pacific Therapeutic Companion Tests Market Size by Region (2020-2025)

8.4 Asia-Pacific Therapeutic Companion Tests Market Size by Region (2026-2031)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia & New Zealand

9 Latin America

9.1 Latin America Therapeutic Companion Tests Market Size (2020-2031)

9.2 Latin America Therapeutic Companion Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031

9.3 Latin America Therapeutic Companion Tests Market Size by Country (2020-2025)

9.4 Latin America Therapeutic Companion Tests Market Size by Country (2026-2031)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Therapeutic Companion Tests Market Size (2020-2031)

10.2 Middle East & Africa Therapeutic Companion Tests Market Growth Rate by Country: 2020 VS 2024 VS 2031

10.3 Middle East & Africa Therapeutic Companion Tests Market Size by Country (2020-2025)

10.4 Middle East & Africa Therapeutic Companion Tests Market Size by Country (2026-2031)

10.5 Israel

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Roche Holdings

11.1.1 Roche Holdings Company Details

11.1.2 Roche Holdings Business Overview

11.1.3 Roche Holdings Therapeutic Companion Tests Introduction

11.1.4 Roche Holdings Revenue in Therapeutic Companion Tests Business (2020-2025)

11.1.5 Roche Holdings Recent Development

11.2 Abbott Laboratories

11.2.1 Abbott Laboratories Company Details

11.2.2 Abbott Laboratories Business Overview

11.2.3 Abbott Laboratories Therapeutic Companion Tests Introduction

11.2.4 Abbott Laboratories Revenue in Therapeutic Companion Tests Business (2020-2025)

11.2.5 Abbott Laboratories Recent Development

11.3 Thermo Fisher Scientific

11.3.1 Thermo Fisher Scientific Company Details

11.3.2 Thermo Fisher Scientific Business Overview

11.3.3 Thermo Fisher Scientific Therapeutic Companion Tests Introduction

11.3.4 Thermo Fisher Scientific Revenue in Therapeutic Companion Tests Business (2020-2025)

11.3.5 Thermo Fisher Scientific Recent Development

11.4 Agilent Technologies

11.4.1 Agilent Technologies Company Details

11.4.2 Agilent Technologies Business Overview

11.4.3 Agilent Technologies Therapeutic Companion Tests Introduction

11.4.4 Agilent Technologies Revenue in Therapeutic Companion Tests Business (2020-2025)

11.4.5 Agilent Technologies Recent Development

11.5 Merck

11.5.1 Merck Company Details

11.5.2 Merck Business Overview

11.5.3 Merck Therapeutic Companion Tests Introduction

11.5.4 Merck Revenue in Therapeutic Companion Tests Business (2020-2025)

11.5.5 Merck Recent Development

11.6 Agendia

11.6.1 Agendia Company Details

11.6.2 Agendia Business Overview

11.6.3 Agendia Therapeutic Companion Tests Introduction

11.6.4 Agendia Revenue in Therapeutic Companion Tests Business (2020-2025)

11.6.5 Agendia Recent Development

11.7 Qiagen

11.7.1 Qiagen Company Details

11.7.2 Qiagen Business Overview

11.7.3 Qiagen Therapeutic Companion Tests Introduction

11.7.4 Qiagen Revenue in Therapeutic Companion Tests Business (2020-2025)

11.7.5 Qiagen Recent Development

11.8 Myriad Genetics

11.8.1 Myriad Genetics Company Details

11.8.2 Myriad Genetics Business Overview

11.8.3 Myriad Genetics Therapeutic Companion Tests Introduction

11.8.4 Myriad Genetics Revenue in Therapeutic Companion Tests Business (2020-2025)

11.8.5 Myriad Genetics Recent Development

11.9 Advanced Cell Diagnostics

11.9.1 Advanced Cell Diagnostics Company Details

11.9.2 Advanced Cell Diagnostics Business Overview

11.9.3 Advanced Cell Diagnostics Therapeutic Companion Tests Introduction

11.9.4 Advanced Cell Diagnostics Revenue in Therapeutic Companion Tests Business (2020-2025)

11.9.5 Advanced Cell Diagnostics Recent Development

11.10 Danaher

11.10.1 Danaher Company Details

11.10.2 Danaher Business Overview

11.10.3 Danaher Therapeutic Companion Tests Introduction

11.10.4 Danaher Revenue in Therapeutic Companion Tests Business (2020-2025)

11.10.5 Danaher Recent Development

11.11 Illumina, Inc

11.11.1 Illumina, Inc Company Details

11.11.2 Illumina, Inc Business Overview

11.11.3 Illumina, Inc Therapeutic Companion Tests Introduction

11.11.4 Illumina, Inc Revenue in Therapeutic Companion Tests Business (2020-2025)

11.11.5 Illumina, Inc Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.1.1 Research Programs/Design

13.1.1.2 Market Size Estimation

13.1.1.3 Market Breakdown and Data Triangulation

13.1.2 Data Source

13.1.2.1 Secondary Sources

13.1.2.2 Primary Sources

13.2 Author Details

13.3 Disclaimer

FEATURED COMPANIES

Thermo Fisher Scientific

Advanced Cell Diagnostics

Danaher

List of Tables

Table 1. Global Therapeutic Companion Tests Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031

Table 2. Key Players of Immunohistochemistry

Table 3. Key Players of Molecular Diagnosis

Table 4. Global Therapeutic Companion Tests Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031

Table 5. Global Therapeutic Companion Tests Market Size by Region (US$ Million): 2020 VS 2024 VS 2031

Table 6. Global Therapeutic Companion Tests Market Size by Region (2020-2025) & (US$ Million)

Table 7. Global Therapeutic Companion Tests Market Share by Region (2020-2025)

Table 8. Global Therapeutic Companion Tests Forecasted Market Size by Region (2026-2031) & (US$ Million)

Table 9. Global Therapeutic Companion Tests Market Share by Region (2026-2031)

Table 10. Therapeutic Companion Tests Market Trends

Table 11. Therapeutic Companion Tests Market Drivers

Table 12. Therapeutic Companion Tests Market Challenges

Table 13. Therapeutic Companion Tests Market Restraints

Table 14. Global Therapeutic Companion Tests Revenue by Players (2020-2025) & (US$ Million)

Table 15. Global Therapeutic Companion Tests Market Share by Players (2020-2025)

Table 16. Global Top Therapeutic Companion Tests Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Therapeutic Companion Tests as of 2024)

Table 17. Ranking of Global Top Therapeutic Companion Tests Companies by Revenue (US$ Million) in 2024

Table 18. Global 5 Largest Players Market Share by Therapeutic Companion Tests Revenue (CR5 and HHI) & (2020-2025)

Table 19. Global Key Players of Therapeutic Companion Tests, Headquarters and Area Served

Table 20. Global Key Players of Therapeutic Companion Tests, Product and Application

Table 21. Global Key Players of Therapeutic Companion Tests, Date of Enter into This Industry

Table 22. Mergers & Acquisitions, Expansion Plans

Table 23. Global Therapeutic Companion Tests Market Size by Type (2020-2025) & (US$ Million)

Table 24. Global Therapeutic Companion Tests Revenue Market Share by Type (2020-2025)

Table 25. Global Therapeutic Companion Tests Forecasted Market Size by Type (2026-2031) & (US$ Million)

Table 26. Global Therapeutic Companion Tests Revenue Market Share by Type (2026-2031)

Table 27. Global Therapeutic Companion Tests Market Size by Application (2020-2025) & (US$ Million)

Table 28. Global Therapeutic Companion Tests Revenue Market Share by Application (2020-2025)

Table 29. Global Therapeutic Companion Tests Forecasted Market Size by Application (2026-2031) & (US$ Million)

Table 30. Global Therapeutic Companion Tests Revenue Market Share by Application (2026-2031)

Table 31. North America Therapeutic Companion Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 32. North America Therapeutic Companion Tests Market Size by Country (2020-2025) & (US$ Million)

Table 33. North America Therapeutic Companion Tests Market Size by Country (2026-2031) & (US$ Million)

Table 34. Europe Therapeutic Companion Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 35. Europe Therapeutic Companion Tests Market Size by Country (2020-2025) & (US$ Million)

Table 36. Europe Therapeutic Companion Tests Market Size by Country (2026-2031) & (US$ Million)

Table 37. Asia-Pacific Therapeutic Companion Tests Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031

Table 38. Asia-Pacific Therapeutic Companion Tests Market Size by Region (2020-2025) & (US$ Million)

Table 39. Asia-Pacific Therapeutic Companion Tests Market Size by Region (2026-2031) & (US$ Million)

Table 40. Latin America Therapeutic Companion Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 41. Latin America Therapeutic Companion Tests Market Size by Country (2020-2025) & (US$ Million)

Table 42. Latin America Therapeutic Companion Tests Market Size by Country (2026-2031) & (US$ Million)

Table 43. Middle East & Africa Therapeutic Companion Tests Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031

Table 44. Middle East & Africa Therapeutic Companion Tests Market Size by Country (2020-2025) & (US$ Million)

Table 45. Middle East & Africa Therapeutic Companion Tests Market Size by Country (2026-2031) & (US$ Million)

Table 46. Roche Holdings Company Details

Table 47. Roche Holdings Business Overview

Table 48. Roche Holdings Therapeutic Companion Tests Product

Table 49. Roche Holdings Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 50. Roche Holdings Recent Development

Table 51. Abbott Laboratories Company Details

Table 52. Abbott Laboratories Business Overview

Table 53. Abbott Laboratories Therapeutic Companion Tests Product

Table 54. Abbott Laboratories Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 55. Abbott Laboratories Recent Development

Table 56. Thermo Fisher Scientific Company Details

Table 57. Thermo Fisher Scientific Business Overview

Table 58. Thermo Fisher Scientific Therapeutic Companion Tests Product

Table 59. Thermo Fisher Scientific Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 60. Thermo Fisher Scientific Recent Development

Table 61. Agilent Technologies Company Details

Table 62. Agilent Technologies Business Overview

Table 63. Agilent Technologies Therapeutic Companion Tests Product

Table 64. Agilent Technologies Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 65. Agilent Technologies Recent Development

Table 66. Merck Company Details

Table 67. Merck Business Overview

Table 68. Merck Therapeutic Companion Tests Product

Table 69. Merck Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 70. Merck Recent Development

Table 71. Agendia Company Details

Table 72. Agendia Business Overview

Table 73. Agendia Therapeutic Companion Tests Product

Table 74. Agendia Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 75. Agendia Recent Development

Table 76. Qiagen Company Details

Table 77. Qiagen Business Overview

Table 78. Qiagen Therapeutic Companion Tests Product

Table 79. Qiagen Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 80. Qiagen Recent Development

Table 81. Myriad Genetics Company Details

Table 82. Myriad Genetics Business Overview

Table 83. Myriad Genetics Therapeutic Companion Tests Product

Table 84. Myriad Genetics Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 85. Myriad Genetics Recent Development

Table 86. Advanced Cell Diagnostics Company Details

Table 87. Advanced Cell Diagnostics Business Overview

Table 88. Advanced Cell Diagnostics Therapeutic Companion Tests Product

Table 89. Advanced Cell Diagnostics Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 90. Advanced Cell Diagnostics Recent Development

Table 91. Danaher Company Details

Table 92. Danaher Business Overview

Table 93. Danaher Therapeutic Companion Tests Product

Table 94. Danaher Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 95. Danaher Recent Development

Table 96. Illumina, Inc Company Details

Table 97. Illumina, Inc Business Overview

Table 98. Illumina, Inc Therapeutic Companion Tests Product

Table 99. Illumina, Inc Revenue in Therapeutic Companion Tests Business (2020-2025) & (US$ Million)

Table 100. Illumina, Inc Recent Development

Table 101. Research Programs/Design for This Report

Table 102. Key Data Information from Secondary Sources

Table 103. Key Data Information from Primary Sources

Table 104. Authors List of This Report

List of Figures

Figure 1. Therapeutic Companion Tests Picture

Figure 2. Global Therapeutic Companion Tests Market Size Comparison by Type (2020-2031) & (US$ Million)

Figure 3. Global Therapeutic Companion Tests Market Share by Type: 2024 VS 2031

Figure 4. Immunohistochemistry Features

Figure 5. Molecular Diagnosis Features

Figure 6. Global Therapeutic Companion Tests Market Size by Application (2020-2031) & (US$ Million)

Figure 7. Global Therapeutic Companion Tests Market Share by Application: 2024 VS 2031

Figure 8. Oncology Case Studies

Figure 9. Cardiovascular Case Studies

Figure 10. Central Nervous System Case Studies

Figure 11. Inflammation Case Studies

Figure 12. Virology Case Studies

Figure 13. Others Case Studies

Figure 14. Therapeutic Companion Tests Report Years Considered

Figure 15. Global Therapeutic Companion Tests Market Size (US$ Million), Year-over-Year: 2020-2031

Figure 16. Global Therapeutic Companion Tests Market Size, (US$ Million), 2020 VS 2024 VS 2031

Figure 17. Global Therapeutic Companion Tests Market Share by Region: 2024 VS 2031

Figure 18. Global Therapeutic Companion Tests Market Share by Players in 2024

Figure 19. Global Therapeutic Companion Tests Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

Figure 20. The Top 10 and 5 Players Market Share by Therapeutic Companion Tests Revenue in 2024

Figure 21. North America Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 22. North America Therapeutic Companion Tests Market Share by Country (2020-2031)

Figure 23. United States Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 24. Canada Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 25. Europe Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 26. Europe Therapeutic Companion Tests Market Share by Country (2020-2031)

Figure 27. Germany Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 28. France Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 29. U.K. Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 30. Italy Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 31. Russia Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 32. Ireland Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 33. Asia-Pacific Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 34. Asia-Pacific Therapeutic Companion Tests Market Share by Region (2020-2031)

Figure 35. China Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 36. Japan Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 37. South Korea Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 38. Southeast Asia Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 39. India Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 40. Australia & New Zealand Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 41. Latin America Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 42. Latin America Therapeutic Companion Tests Market Share by Country (2020-2031)

Figure 43. Mexico Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 44. Brazil Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 45. Middle East & Africa Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 46. Middle East & Africa Therapeutic Companion Tests Market Share by Country (2020-2031)

Figure 47. Israel Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 48. Saudi Arabia Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 49. UAE Therapeutic Companion Tests Market Size YoY Growth (2020-2031) & (US$ Million)

Figure 50. Roche Holdings Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 51. Abbott Laboratories Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 52. Thermo Fisher Scientific Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 53. Agilent Technologies Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 54. Merck Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 55. Agendia Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 56. Qiagen Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 57. Myriad Genetics Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 58. Advanced Cell Diagnostics Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 59. Danaher Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 60. Illumina, Inc Revenue Growth Rate in Therapeutic Companion Tests Business (2020-2025)

Figure 61. Bottom-up and Top-down Approaches for This Report

Figure 62. Data Triangulation

Figure 63. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Isopropyl Alcohol Antiseptic Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-37F12574

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Medical Thermal Imaging Devices Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-15J20209

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Total Foot System Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-8O12834

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

Global Adult Nasogastric Feeding Tube Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-36J12622

Wed Dec 03 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions